PMID: 35172273
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
Pece Salvatore, Sestak Ivana, Montani Francesca, Tillhon Micol, Maisonneuve Patrick, Freddi Stefano, Chu Kim, Colleoni Marco, Veronesi Paolo, Disalvatore Davide
European journal of cancer (Oxford, England : 1990) · 2022
Vol. 164, pp. 52-61
This entry links to third-party literature. For research use only.
AnastrozoleBiomarkers, TumorBreast NeoplasmsFemaleHumansNeoplasm Recurrence, LocalPrognosisErb-b2 Receptor Tyrosine KinasesRetrospective StudiesTamoxifen